Buen Buen & Co., CPAs

📣 𝗡𝗢𝗧𝗜𝗖𝗘: 𝗘𝘅𝘁𝗲𝗻𝘀𝗶𝗼𝗻 𝗼𝗳 𝘁𝗵𝗲 𝗗𝗲𝗮𝗱𝗹𝗶𝗻𝗲 𝗳𝗼𝗿 𝗙𝗶𝗹𝗶𝗻𝗴 𝗼𝗳 𝟮𝟬𝟮𝟱 𝗔𝗻𝗻𝘂𝗮𝗹 𝗙𝗶𝗻𝗮𝗻𝗰𝗶𝗮𝗹 𝗦𝘁𝗮𝘁𝗲𝗺𝗲𝗻𝘁𝘀 (𝗔𝗙𝗦)

The filing deadline for the 2025 Annual Financial Statements (AFS) and related reportorial requirements has been 𝗘𝗫𝗧𝗘𝗡𝗗𝗘𝗗. This follows the issuance of Revenue Memorandum Circular No. 30-2026 by the Bureau of Internal Revenue (BIR).

🗓️ Revised Deadlines:
• Annual Financial Statements of All Corporations: 𝗝𝘂𝗻𝗲 𝟭𝟱, 𝟮𝟬𝟮𝟲
• SEC Form 52-AR of Brokers & Dealers: 𝗠𝗮𝘆 𝟭𝟱, 𝟮𝟬𝟮𝟲
• Annual Reports (SEC Form 17-A) with AFS as attachment: 𝗠𝗮𝘆 𝟭𝟱, 𝟮𝟬𝟮𝟲

All corporations are reminded to ensure that submitted AFS are duly received by the BIR.

Read the full notice here: https://www.sec.gov.ph/notices-2026/extension-of-the-deadline-for-filing-of-2025-annual-financial-statements-afs/

𝗕𝗜𝗥 𝗣𝗨𝗕𝗟𝗜𝗦𝗛𝗘𝗦 𝗨𝗣𝗗𝗔𝗧𝗘𝗗 𝗟𝗜𝗦𝗧 𝗢𝗙 𝟮,𝟮𝟲𝟯 𝗩𝗔𝗧-𝗘𝗫𝗘𝗠𝗣𝗧 𝗠𝗘𝗗𝗜𝗖𝗜𝗡𝗘𝗦

The Bureau of Internal Revenue (BIR) issued Revenue Memorandum Circular (RMC) No. 27-2026 on April 8, 2026, publishing the FDA-endorsed full list of VAT-exempt drugs under Republic Act No. 10963, or the TRAIN Law, and Republic Act No. 11534, or the CREATE Act.

The Food and Drug Administration Philippines (FDA) of the Department of Health (Philippines) endorsed the updated list of 2,263 VAT-exempt drugs for the treatment of the following illnesses: 702 for cancer, 535 for hypertension, 327 for diabetes, 300 for mental illness, 171 for high cholesterol, 152 for kidney disease, and 76 for tuberculosis.

In line with President Ferdinand R. Marcos Jr.’s directive to make healthcare more accessible and affordable for Filipinos, the Department of Finance, under Finance Secretary Frederick D. Go, supports the timely implementation of measures that help reduce the cost of essential medicines.

BIR Commissioner Charlito Martin R. Mendoza said, “This issuance forms part of the government’s continuing efforts to help ease the cost of essential medicines, especially for Filipinos managing chronic and critical illnesses.”

RMC No. 27-2026 further provides that the updated list supersedes previous revenue memorandum circulars issued on the matter and shall remain in effect until new updates are endorsed by the FDA.

You may access the full text of RMC No. 27-2026 here(https://bir-cdn.bir.gov.ph/BIR/pdf/RMC%20No.%2027-2026.pdf), while the complete list of VAT-exempt medicines is available through Annex A of the circular (https://bir-cdn.bir.gov.ph/BIR/pdf/Annex%20A%20of%20RMC%20No.%2027-2206%20(1).pdf).

𝗔𝗡𝗡𝗨𝗔𝗟 𝗜𝗡𝗖𝗢𝗠𝗘 𝗧𝗔𝗫 𝗥𝗘𝗧𝗨𝗥𝗡 𝗗𝗘𝗔𝗗𝗟𝗜𝗡𝗘 𝗠𝗢𝗩𝗘𝗗 𝗧𝗢 𝗠𝗔𝗬 𝟭𝟱, 𝟮𝟬𝟮𝟲

The Bureau of Internal Revenue (BIR) has issued Revenue Memorandum Circular No. 30-2026, extending the deadline to May 15, 2026 for the filing of 2025 Annual Income Tax Returns, payment of the corresponding taxes due thereon, and submission of required attachments.

“In line with the directive of President Ferdinand R. Marcos Jr., this extension is meant to make tax compliance easier for taxpayers at a time when many are managing added strain from the ongoing energy crisis,” Commissioner Charlito Martin R. Mendoza said.

Taxpayers may file through the BIR’s electronic filing platforms and pay electronically through available payment platforms, or manually through the nearest Authorized Agent Banks.

RMC No. 30-2026: https://tinyurl.com/RMC302026

BIR Interactive Digital Tax Calendar 𝗕𝗜𝗥 𝗹𝗮𝘂𝗻𝗰𝗵𝗲𝘀 𝗳𝗶𝗿𝘀𝘁-𝗲𝘃𝗲𝗿 𝗜𝗻𝘁𝗲𝗿𝗮𝗰𝘁𝗶𝘃𝗲 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗧𝗮𝘅 𝗖𝗮𝗹𝗲𝗻𝗱𝗮𝗿 𝗳𝗼𝗿 𝟮𝟬𝟮𝟲The Bureau of Internal Revenue (BIR)...

📣 𝗦𝗘𝗖 𝘀𝗲𝘁𝘀 𝗱𝗲𝗮𝗱𝗹𝗶𝗻𝗲 𝗳𝗼𝗿 𝗔𝗙𝗦, 𝗚𝗜𝗦 𝗳𝗶𝗹𝗶𝗻𝗴 𝗳𝗼𝗿 𝟮𝟬𝟮𝟲

The Securities and Exchange Commission (SEC) has issued the schedule for the submission of corporations’ annual financial statements (AFS) and general information sheets (GIS) for 2026.

The SEC on February 11 issued Memorandum Circular No. 9, Series of 2026, which provides for the schedule of the 2026 Filing of Annual Financial Statements and General Information Sheets.

The AFS and GIS shall be filed through the Electronic Filing and Submission Tool, or eFAST. Other reports not yet accepted through eFAST shall be submitted through the iMessage Online Ticketing System at imessage.sec.gov.ph.

🔗 Read the full Memorandum Circular here: https://www.sec.gov.ph/mc-2026/sec-mc-no-09-series-of-2026/